OUR REASON TO EXIST
Captario began with a clear vision of addressing the major pain points within the drug development process. Through the years, Captario has remained true to this vision. Traditional ways of working no longer support the needs of today’s complex pharma industry landscape.
We believe the use of augmented intelligence, advanced Monte Carlo simulation (MCS) and data analytics are crucial for success in a competitive environment. An environment with challenges that include low regulatory approval rates, increasingly high R&D costs, and intellectual property challenges.
With its headquarters in downtown Gothenburg, Sweden, Captario is an innovator in the pharma industry with an accomplished and talented workforce of management, statisticians, mathematicians, optimization experts, pharma analysts and developers.
In our continued efforts to be closer to customers, Captario is also situated in the United States. Located in New York, we further strengthened our US presence by adding experienced customer support analysts.
Captario is a private company with strong financial backing from Swedish investors including Investment AB Spiltan and Almi Invest.
Founded in 2012, we are currently scaling up and looking ahead to growth in 2020 and beyond. You can contact us below, if you’re interested in learning more about investment opportunities.
Johannes Vänngård, CEO
Erik Post, CFO